Lovenox and Meningioma - a phase IV clinical study of FDA data

Summary:

Meningioma is reported as a side effect among people who take Lovenox (enoxaparin sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Meningioma when taking Lovenox. It is created by eHealthMe based on reports of 47,547 people who have side effects when taking Lovenox from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Meningioma?

Meningioma (a diverse set of tumours arising from the meninges) is found to be associated with 474 drugs and 581 conditions by eHealthMe. Check the latest studies of Meningioma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

47,547 people reported to have side effects when taking Lovenox.
Among them, 47 people (0.1%) have Meningioma.

Among these 47 people:

How long have people been on Lovenox when they have Meningioma? *

What is the gender of people who have Meningioma when taking Lovenox? *

female: 58.7 %
male: 41.3 %

What is the age of people who have Meningioma when taking Lovenox? *

What are other drugs people take besides Lovenox? *

What are other side effects people have besides Meningioma? *

Stress And Anxiety: 39 people, 82.98%
Pain: 38 people, 80.85%
Thrombocytopenia (decrease of platelets in blood): 38 people, 80.85%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 37 people, 78.72%
Depression: 37 people, 78.72%
Bone Lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries): 36 people, 76.60%
Intervertebral Disc Disorder (spinal disc disorder): 35 people, 74.47%
Infection: 35 people, 74.47%
Tooth Loss: 34 people, 72.34%
Plasmacytoma (neoplasm of plasma cells (usually in bone marrow)): 34 people, 72.34%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 19 people, 40.43%
Multiple Myeloma (cancer of the plasma cells): 16 people, 34.04%
Bone Disorder: 6 people, 12.77%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 4.26%
Post Procedural Hypothyroidism: 2 people, 4.26%
Hypouricaemia (level of uric acid in the blood that is abnormally high): 2 people, 4.26%
Diarrhea: 2 people, 4.26%
Sleep Disorder: 1 person, 2.13%
Anaesthesia: 1 person, 2.13%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and have Meningioma?

- Check whether Meningioma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lovenox:

Lovenox (48,149 reports)

Meningioma treatments and more:

Meningioma (4,819 reports)

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Meningioma:

Meningioma (474 drugs)

Browse all the conditions that are associated with Meningioma:

Meningioma (581 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Lovenox) and Lovenox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.